Trial Details

COMPLETED
Basic Information
Clinical ID c4736
Identifier NCT00048295
Trial Title Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Alicaforsen
Participant Information
Sponsor Ionis Pharmaceuticals, Inc.
City Kortrijk
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2002-05
Primary Completion Date -
Completion Date -